MARQUETTE – Rob Winn, a biology professor at Northern Michigan University, will be presenting a seminar titled, “Manipulating the Immune System to Produce New Cancer Treatments.”
Winn spent the past summer working in Seattle with scientists at Dendreon Corporation. Dendreon’s goal is to produce vaccines that modify antigens – which are produced on the surface of cancer cells – so that the human immune system recognizes them and activates a response that will rid the body of them.
Targeting only cancerous cells is favorable to chemotherapy or radiation treatments, which also affect normal cells and often create undesirable side effects. Winn is now supervising NMU research on the subject.
Winn will talk about the research he did this summer and provide a general background on the current research.
The seminar is at 3 p.m. Friday, Nov. 8, in the New Science Facility room 2204 at NMU. The public is welcome to attend this free event.